Annelot P. Smit

Annelot P. Smit

Auto-generated profile, based on publicly available information

Annelot P. Smit

Center for Prevention, Lifestyle and Health, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2024 in Age and Ageing
Verified
Journal Article
Open access
PDF file
ASAnnelot P Smit
Annelot P Smit
GHGerrie-Cor M Herber
Gerrie-Cor M Herber
LKLieke M Kuiper
Lieke M Kuiper
MRM. Liset Rietman
M. Liset Rietman
KWKirsten E J Wesenhagen
Kirsten E J Wesenhagen
WVW M Monique Verschuren
W M Monique Verschuren
Metabolomic scores based on age (MetaboAge) and mortality (MetaboHealth) are considered indicators of overall health, but their association with cognition in the general population is unknown. Therefore, the association between MetaboAge/MetaboHealth and level and decline in cognition was studied, as were differences between men and women. Data of 2821 participants (50% women, age range 45–75) from the Doetinchem Cohort Study was used. MetaboAge and MetaboHealth were calculated from 1H-NMR metabolomics data at baseline. Cognitive domain scores (memory, flexibility and processing speed) and global cognitive functioning were available over a 10-year period. The association between MetaboAge/MetaboHealth and level of cognitive functioning was studied using linear regressions while for the association between MetaboAge/MetaboHealth and cognitive decline longitudinal linear mixed models were used. Analyses were adjusted for demographics and lifestyle factors. Higher MetaboAge, indicating poorer metabolomic ageing, was only associated with lower levels of processing speed in men. Higher MetaboHealth, indicating poorer immune-metabolic health, was associated with lower levels of cognitive functioning for all three domains and global cognitive functioning in both men and women. Only in men, MetaboHealth was also associated with 10-year decline in flexibility, processing speed and global cognition. Metabolites that contributed to the observed associations were in men mainly markers of protein metabolism, and in women mainly markers of lipid metabolism and inflammatory metabolites. MetaboHealth, not MetaboAge, was associated with cognitive functioning independent of conventional risk factors. Individual metabolites affect cognitive functioning differently in men and women, suggesting sex-specific pathophysiological pathways underlying cognitive functioning.

29 August 2023 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Open access
PDF file
ASAnnelot P Smit
Annelot P Smit
GHGerrie-Cor M Herber
Gerrie-Cor M Herber
LKLieke M Kuiper
Lieke M Kuiper
BLBette Loef
Bette Loef
HPH Susan J Picavet
H Susan J Picavet
WVW M Monique Verschuren
W M Monique Verschuren
People age differently. Differences in aging might be reflected by metabolites, also known as metabolomic aging. Predicting metabolomic aging is of interest in public health research. However, the added value of longitudinal over cross-sectional predictors of metabolomic aging is unknown. We studied exposome-related exposures as potential predictors of metabolomic aging, both cross-sectionally and longitudinally in men and women. We used data from 4 459 participants, aged 36–75 of Round 4 (2003–2008) of the long-running Doetinchem Cohort Study (DCS). Metabolomic age was calculated with the MetaboHealth algorithm. Cross-sectional exposures were demographic, biological, lifestyle, and environmental at Round 4. Longitudinal exposures were based on the average exposure over 15 years (Round 1 [1987–1991] to 4), and trend in these exposure over time. Random Forest was performed to identify model performance and important predictors. Prediction performances were similar for cross-sectional and longitudinal exposures in both men (R2 6.8 and 5.8, respectively) and women (R2 14.8 and 14.4, respectively). Biological and diet exposures were most predictive for metabolomic aging in both men and women. Other important predictors were smoking behavior for men and contraceptive use and menopausal status for women. Taking into account history of exposure levels (longitudinal) had no added value over cross-sectionally measured exposures in predicting metabolomic aging in the current study. However, the prediction performances of both models were rather low. The most important predictors for metabolomic aging were from the biological and lifestyle domain and differed slightly between men and women.

7 January 2026 in Exposome
Verified
Journal Article
Open access
ASAnnelot P Smit
Annelot P Smit
BLBette Loef
Bette Loef
JHJurriaan Hoekstra
Jurriaan Hoekstra
JLJeroen Lakerveld
Jeroen Lakerveld
NJNicole A H Janssen
Nicole A H Janssen
WVW M Monique Verschuren
W M Monique Verschuren
Introduction: Sociodemographic, lifestyle, environmental, and neighborhood exposures are associated with Diabetes Mellitus type 2 (DM-2). Yet, studies that include exposures from all these domains remain limited. In this study, the association between a wide range of exposures across these domains and DM-2 incidence was investigated, stratified by sex. Methods: Data from the 2012 Dutch national health survey was used (N = 237 644), enriched with exposure data from multiple sources. In total, 57 sociodemographic, lifestyle, environmental and neighborhood exposures were included. Incidence of DM-2 was based on medication prescription from 2013 to 2022. The most important exposures for DM-2 were identified using Random Forest. Subsequently, the associations between the selected exposures and DM-2 incidence were assessed via a Cox regression, stratified by sex. Results: In total, 5328 men and 4298 women developed DM-2 between 2013 and 2022. BMI, age and sex were identified as the most important predictors. The top 15-ranked exposures were included in the Cox regression models. BMI, age and lifestyle exposures (eg, alcohol consumption, physical activity and smoking) were associated with DM-2 in both men and women. Only in men, neighborhood exposures such as property value were associated with DM-2, while education was associated with DM-2 only in women. No associations were found for environmental exposures. Conclusions: These results substantiate that sociodemographic and lifestyle exposures are important targets for DM-2 prevention and outperform neighborhood and environmental exposures. We observed sex-specific associations, highlighting the importance of using a sex-stratified approach in future research and clinical practice.

14 January 2026 in Global Heart
Verified
Journal Article
Open access
PDF file
Silvia Juliana Trujillo CáceresSilvia Juliana Trujillo Cáceres
Silvia Juliana Trujillo Cáceres
SJSilvia Juliana
Silvia Juliana
ASAnnelot P. Smit
Annelot P. Smit
VAVicente Artola Arita
Vicente Artola Arita
MMMarilyne Menassa
Marilyne Menassa
WVW. M. Monique Verschuren
W. M. Monique Verschuren
Background: While life expectancy (LE) in the Netherlands has increased over recent decades, it is not always accompanied by good health, particularly among individuals with adiposity. As adiposity is a major risk factor for cardiovascular disease (CVD), previous studies have explored its association with LE and CVD burden, but findings remain heterogeneous. Objective: To assess the association between adiposity and LE in adults, with and without CVD. Methods: We used data from the longitudinal Doetinchem Cohort Study (DCS), including 2,323 participants aged 50–70 years (49% women). Adiposity categories were determined (low, increased, high and very high) based on the combination of body mass index (BMI) and waist circumference (WC) thresholds for overweight and obesity based on the AACE/ACE definitions. CVD and mortality were assessed via linkage to hospital and death registries. A multistate life table approach estimated total and CVD-specific LE using transition rates between three health states—CVD-free to CVD, CVD-free to death, and CVD to death—incorporating prevalences and adjusted hazard ratios (HRs) for adiposity categories by sex and CVD status. Results: LE did not differ between adiposity categories at age 50 in both men and women. Men with very high adiposity had a 2.6-year lower LE free of CVD compared to men in the low adiposity category (difference: –2.6 years, 95% CI: –3.6, –1.5), and lived more years with CVD (difference: 2 years, 95% CI: 0.9, 2.9). Men in any adiposity category lived more years with CVD than women in a similar category. In women, there were no differences in CVD-specific LE between the adiposity categories. Conclusion: Men in the very high adiposity category lived more years with CVD compared to those in the low category. These findings highlight the need for targeted cardiovascular prevention in men with very high adiposity to delay CVD onset and promote a healthy lifespan.

23 July 2026 in Environmental Research
Verified
Journal Article
Open access
ASAnnelot P. Smit
Annelot P. Smit
BLBette Loef
Bette Loef
JKJochem O. Klompmaker
Jochem O. Klompmaker
JLJeroen Lakerveld
Jeroen Lakerveld
NJNicole A.H. Janssen
Nicole A.H. Janssen
WVW.M. Monique Verschuren
W.M. Monique Verschuren